Cite
MLA Citation
Z. Yu et al.. “RAD140, an orally available selective androgen receptor modulator, exhibits potent anti-tumor activity in ER+AR+ breast cancer models.” European journal of cancer, vol. 69, n.d., pp. S149–. http://access.bl.uk/ark:/81055/vdc_100039473461.0x000056